PBYI NASDAQ · Healthcare · FY 2025-12-31

PUMA BIOTECHNOLOGY, INC.

0.02.14.36.48.6ABVfair 1.76buy —EPVfair 5.19buy ≤ 2.33EBVfair 5.72buy ≤ 2.57DBVnot valid for this companyprice 7.93 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●●○ Medium · 3/4

Price
7.930 USD
Market cap
399.7M USD
P / B
3.07
P / E
13.00
EPS
0.610
DPS / yield
(0.0%)
NAV / share
1.765
Graham number
5.957
Z'' score
-13.97
Piotroski F
6 / 9
Beneish M
-2.05
ROIC vs WACC
28.5% vs 12.8%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.